MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Concordia Healthcare Company Profile (NASDAQ:CXRX)

Consensus Ratings for Concordia Healthcare (NASDAQ:CXRX) (?)
Ratings Breakdown: 3 Hold Rating(s), 9 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $55.13 (157.96% upside)

Analysts' Ratings History for Concordia Healthcare (NASDAQ:CXRX)
Show:
DateFirmActionRatingPrice TargetActions
6/21/2016RBC CapitalReiterated RatingOutperform$73.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Goldman SachsInitiated CoverageNeutral$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016TD SecuritiesReiterated RatingBuy$48.00 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2016LaurentianReiterated RatingBuy$60.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/29/2016CIBCBoost Price TargetSector Performer$31.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Laurentian Bank of CanadaLower Price TargetBuy$60.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/21/2016Dundee SecuritiesLower Price Target$46.50 -> $45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015MackieReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2015ScotiabankReiterated RatingSector Outperform$80.00 -> $75.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/16/2015S&P Equity ResearchReiterated RatingBuy$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/10/2015Howard WeilInitiated CoverageOutperform$90.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Concordia Healthcare (NASDAQ:CXRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
5/13/2016Q116$1.54$1.35$231.00 million$228.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/23/2016Q415$1.32$1.24$166.60 million$191.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/12/2015Q315$1.43$1.46$93.11 million$94.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/13/2015Q215$0.91$0.96$84.47 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Concordia Healthcare (NASDAQ:CXRX)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$1.35$1.35$1.35
Q2 20161$1.52$1.52$1.52
Q3 20161$1.62$1.62$1.62
Q4 20161$1.68$1.68$1.68
(Data provided by Zacks Investment Research)
Dividend History for Concordia Healthcare (NASDAQ:CXRX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/16/2016quarterly$0.081.03%7/13/20167/15/20167/29/2016Tweet This Announcement  Share This Announcement on StockTwits
3/24/2016quarterly$0.081.13%4/13/20164/15/20164/29/2016Tweet This Announcement  Share This Announcement on StockTwits
11/17/2015quarterly$0.080.92%1/13/20161/15/20161/29/2016Tweet This Announcement  Share This Announcement on StockTwits
8/14/2015quarterly$0.080.39%10/13/201510/15/201510/30/2015Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Concordia Healthcare (NASDAQ:CXRX)
No insider trades for this company have been tracked by MarketBeat.com

Latest Headlines for Concordia Healthcare (NASDAQ:CXRX)
DateHeadline
06/25/16 07:23 AMIs Selling Concordia Healthcare Corp Here a Winning Strategy? The Stock Just Gapped Down - Engelwood Daily
06/23/16 02:25 PMRecently Issued Stock Ratings For Concordia Healthcare Corp. (NASDAQ:CXRX) - Fiscal Standard
06/21/16 08:14 AMConcordia Healthcare Up 4% - Says Analysis of PDT with Photofrin Positive, To Pay $12.5 Mln to Settle Arbitration Proceeding
06/20/16 03:28 PMConcordia Healthcare Up 4% - Says Analysis of PDT with Photofrin Positive, To Pay $12.5 Mln to Settle Arbitration ... - Nasdaq
06/20/16 03:28 PMConcordia Healthcare Corp. (NASDAQ:CXRX) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 08:04 AMConcordia Healthcare Announces PDT with Photofrin® Data and Provides Corporate Update
06/17/16 04:11 PMETF’s with exposure to Concordia Healthcare Corp. : June 17, 2016 -
06/10/16 07:14 AMConcordia Healthcare sees upside bet -
06/08/16 09:16 AMMoody's: US Specialty Pharma's M&A focus shifts to pipelines and innovative products -
06/08/16 07:03 AMApollo Global (APO) Submits Bid to Acquire Concordia -
06/06/16 07:55 PMBenzinga's M&A Chatter for Monday June 6, 2016 - The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday June 6, 2016: Apollo Global Management Said to Still be in Talks to Acquire Concordia Healthcare The Rumor:Apollo Global Management LLC (NYSE: APO) is still in talks to acquire Concordia Healthcare Corp. (NASDAQ: CXRX), according to sources as reported by Dow Jones on Monday. While two other private-equity firms dropped out of the bidding process over regulatory concerns, Apollo submitted a bid in the final round, the sources said. Concordia Healthcare rose $0.18 Monday, to close at $26.71. ManpowerGroup to Acquire Dutch Business of Ciber for $25M in Cash The Deal:Ciber Nederland B.V., a subsidiary of Ciber, Inc. (NYSE: CBR) and ManpowerGroup Netherlands B.V. (NYSE: MAN) announced Monday, that they have signed a purchase agreement for the sale of certain of the assets and liabilities of Ciber Nederland. The purchase price is $25 million in cash purchase price, subject to a price adjustment related to the retention of certain Ciber Nederland customers, plus an escrow amount of $5.0 million of the purchase price. Manpower closed at $79.06 on Monday, up $0.27. eFuture Reports Preliminary Non-Binding Proposal from Shiji of $6.32/Share The Offer:eFuture Holding Inc. (NASDSThe following are the M&A deals, rumors and chatter circulating on Wall Street for Monday ...Full story available on Benzinga.com
06/06/16 03:22 PMApollo Still in Talks to Buy Concordia
06/06/16 02:34 PMHow Did Biotech ETFs Perform in the Week Ended June 3? -
06/06/16 07:49 AMThe Wall Street Journal: Apollo Global Management is still in talks to buy Concordia Healthcare - Apollo Global Management LLC is still in talks to buy Concordia Healthcare Corp. after two other private-equity firms walked away over concern that tighter regulatory scrutiny of pharmaceutical companies might hurt the Canadian pharmaceutical company’s earnings.
06/06/16 04:50 AMConcordia Healthcare Corporation (NASDAQ:CXRX) Short Interest Increased By 43.06% - HNN
06/05/16 10:13 AMWhy Did Concordia Healthcare Corp. Drop Over 20% Yesterday?
06/03/16 02:16 PMETF’s with exposure to Concordia Healthcare Corp. : June 3, 2016 -
06/03/16 10:40 AMConcordia Healthcare Corp (NASDAQ:CXRX) Stock Update & Estimates - Stock Tick Tock
06/02/16 09:33 PMBlackstone (BX), Carlyle Said to Walk From Concordia Healthcare (CXRX) Deal - WSJ - StreetInsider.com - Bidness ETCBlackstone (BX), Carlyle Said to Walk From Concordia Healthcare (CXRX) Deal - WSJStreetInsider.comPrivate equity firms Blackstone (NYSE: BX) and Carlyle (NYSE: CG) walked away from the auction process for Concordia Healthcare (Nasdaq: CXRX), according to the Wall Street Journal, citing people familiar. The report states that final bids for ...Here's Why Concordia Healthcare Corp (CXRX) Stock Took a Turn for the Worst TodayBidness ETCConcordia Healthcare Plunges, Attempts To ReboundBenzingaAnalyst Review: Concordia Healthcare Corp. (NASDAQ:CXRX)Risers & FallersFranklin Independent -The Motley Fool Canada -Stock Tick Tockall 19 news articles »
06/02/16 02:37 PMBRIEF-Concordia Healthcare confirms that review of strategic alternatives ongoing - * Concordia Healthcare confirms that review of strategic alternatives ongoing Source text for Eikon: Further company coverage:
06/02/16 02:08 PMConcordia Healthcare Confirms That Review of Strategic Alternatives Ongoing - [CNW Group] - Concordia Healthcare Confirms That Review of Strategic Alternatives Ongoing
06/02/16 09:50 AMConcordia Healthcare (CXRX) Completes Previously Announced Acquisition of Four Generic Products - StreetInsider.com - Concordia Healthcare (CXRX) Completes Previously Announced Acquisition of Four Generic ProductsStreetInsider.comConcordia Healthcare Corp. (NASDAQ: CXRX) announced that it has completed the acquisition of the global rights to four generic products, as previously announced on May 13, 2016. These products include Sodium Feredetate oral solution for the treatment ...Concordia Healthcare Corp (NASDAQ:CXRX): Company Rating and Earnings RoundupFranklin IndependentIs Concordia Healthcare Corp. Too Cheap to Ignore?The Motley Fool CanadaConcordia Healthcare Corporation (NASDAQ:CXRX) Short Interest Increased By 43.06%HNNall 4 news articles »
06/01/16 09:42 PMConcordia Healthcare Completes Acquisition of Four Generic Products - PR Newswire (press release) - Concordia Healthcare Completes Acquisition of Four Generic ProductsPR Newswire (press release)OAKVILLE, ON, June 1, 2016 /PRNewswire/ - Concordia Healthcare Corp. ("Concordia" or the "Company") (NASDAQ: CXRX) (TSX: CXR), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, announced ...Is Concordia Healthcare Corp. Too Cheap to Ignore?The Motley Fool Canadaall 3 news articles »
06/01/16 06:22 PMConcordia Healthcare Completes Acquisition of Four Generic Products - [CNW Group] - Concordia Healthcare Completes Acquisition of Four Generic Products
06/01/16 12:31 PMConcordia Healthcare Corp. :CXRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 1, 2016 -
05/31/16 07:36 AMResearch Analysts' Recent Ratings Updates for Concordia Healthcare (CXRX) - Let Me Know About This - Research Analysts' Recent Ratings Updates for Concordia Healthcare (CXRX)Let Me Know About ThisConcordia Healthcare (NASDAQ:CXRX) traded up 5.95% during trading on Monday, reaching $32.95. The company had a trading volume of 913,153 shares. Concordia Healthcare has a 12-month low of $19.02 and a 12-month high of $89.10. The firm's 50 ...
05/21/16 01:06 PMRevenue Update on Concordia Healthcare Corp(NASDAQ:CXRX) - Trade Calls - Revenue Update on Concordia Healthcare Corp(NASDAQ:CXRX)Trade CallsConcordia Healthcare Corp(NASDAQ:CXRX) announced the earnings results for Fiscal Year 2016 and Q1. The results came in during Pre-market on May 13, 2016. Company reported revenue of $228.53M. Analysts estimated a revenue of $231.00M.Latest Analyst Ratings For Concordia Healthcare Corp. (NASDAQ:CXRX)Share Trading NewsCan Concordia Healthcare Corp's Tomorrow be Different? The Stock Declines AgainFranklin Independentall 3 news articles »
05/18/16 09:24 PMETF’s with exposure to Concordia Healthcare Corp. : May 19, 2016 -
05/17/16 07:13 AMConcordia Healthcare Corp. breached its 50 day moving average in a Bullish Manner : CXRX-US : May 17, 2016 -
05/13/16 01:38 PM10 Biggest Mid-Day Market Gainers - Evolent Health (NYSE: EVH) trading up 20.24% after beating earnings estimates. Oramed (NASDAQ: ORMP) up 13.38% after news that Oramed's patent was being granted in china for oral administration of proteins Nvida (NASDAQ: NVDA) was up 12.59% after several upgrades and a big earnings beat. Concordia Healthcare Corp. (NASDAQ: CXRX) up ...Full story available on Benzinga.com
05/13/16 12:12 PMConcordia Healthcare (CXRX) Misses Q1 EPS by 17c; Announces Acquisition of Four Products - StreetInsider.com - Concordia Healthcare (CXRX) Misses Q1 EPS by 17c; Announces Acquisition of Four ProductsStreetInsider.comConcordia Healthcare (NASDAQ: CXRX) reported Q1 EPS of $1.35, $0.17 worse than the analyst estimate of $1.52. Revenue for the quarter came in at $228.5 million versus the consensus estimate of $231 million. The Company also announced today that ...Concordia Healthcare Q1 Results Miss ExpectationsBenzingaConcordia Healthcare's (CXRX) CEO Mark Thompson on Q1 2016 Results - Earnings Call TranscriptSeeking AlphaConcordia Healthcare Q1 Results Mixed vs. Street Estimates (NASDAQ:CXRX)Sonoran Weekly ReviewMarket Digest -Canada NewsWire (press release)all 9 news articles »
05/13/16 09:19 AMHere’s Why These Five Stocks Are Trending on Friday -
05/13/16 08:22 AMConcordia Healthcare Q1 Results Miss Expectations - Concordia Healthcare Corp (NASDAQ: CXRX) suffered a GAAP net loss in the first quarter compared to a profit in the last year's same quarter. Revenue jumped 570 percent year-over-year due to some acquisitions, but was not enough to meet the Street analysts' estimations. The company's adjusted earnings also failed to come in line. Concordia Healthcare reported net loss from continuing operations of $4.8 million or a loss per share of $0.09 for the first quarter. In comparison, the company earned net income from continuing ...Full story available on Benzinga.com
05/13/16 06:13 AMConcordia Healthcare reports 1Q loss -
05/13/16 05:46 AMBRIEF-Concordia Healthcare qtrly adjusted EPS $1.35 - * Reaffirms 2016 guidance 2 of $1,020 million to $1,060 million in revenue and adjusted EBITDA of $610 million to $640 million
05/13/16 05:27 AMConcordia Healthcare misses by $0.17, misses on revenue -
05/13/16 05:27 AMConcordia Healthcare declares $0.075 dividend -
05/13/16 05:14 AM6:14 am Concordia Healthcare misses by $0.05, reports revs in-line; reaffirms FY16 EPS guidance, revs guidance -
05/13/16 05:00 AMConcordia Healthcare Announces First Quarter 2016 Results and Acquisition of Four Products with Global Rights - [CNW Group] - Concordia Healthcare Announces First Quarter 2016 Results and Acquisition of Four Products with Global Rights
05/11/16 12:28 PMConsensus Rating Review for Concordia Healthcare Corp (NASDAQ:CXRX) - B.O.D.Y Confidential - Consensus Rating Review for Concordia Healthcare Corp (NASDAQ:CXRX)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1.75 on shares of Concordia Healthcare Corp (NASDAQ:CXRX). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy ...and more »
05/08/16 11:38 AMNext Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX) - Share Trading News - Next Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX)Share Trading News03/29/2016 – Concordia Healthcare Corp. had its “sector performer” rating reiterated by analysts at CIBC. They now have a USD 34 price target on the stock. 03/28/2016 – Concordia Healthcare Corp. had its “buy” rating reiterated by analysts at TD ...Are Analysts Bearish Concordia Healthcare Corp (NASDAQ:CXRX) After Last Week?Franklin IndependentConcordia Healthcare Corp Could Burn Your Portfolio. Has Another Gap DownThe Postall 3 news articles »
05/06/16 12:46 PMNebula Capital Management’s Biggest Q1 Moves -
05/03/16 07:28 AMConcordia Healthcare Corp. breached its 50 day moving average in a Bearish Manner : CXRX-US : May 3, 2016 -
04/30/16 12:23 PMMarket Chatter: Concordia Healthcare Drops 4% as Co Looks for Private Equity Bidders: Bloomberg - Nasdaq - Financial PostMarket Chatter: Concordia Healthcare Drops 4% as Co Looks for Private Equity Bidders: BloombergNasdaqConcordia Healthcare ( CXRX ) shares dropped over 4% on Friday after a Bloomberg report cited people familiar with the matter as saying the company is working with Greenhill & Co. to find potential private equity bidders. The company and its advisers ...Bloomberg: Concordia Healthcare working with Greenhill on saleSeeking Alphaall 3 news articles »
04/29/16 05:15 PMConcordia Healthcare Reports Results of Annual General and Special Meeting of Shareholders - [CNW Group] - Concordia Healthcare Reports Results of Annual General and Special Meeting of Shareholders
04/29/16 01:58 PMBloomberg: Concordia Healthcare working with Greenhill on sale -
04/27/16 12:42 PMMontrusco Bolton Investments Lowers stake in Concordia Healthcare Corp (CXRX) - Market Digest - Montrusco Bolton Investments Lowers stake in Concordia Healthcare Corp (CXRX)Market DigestConcordia Healthcare Corp (CXRX) : Montrusco Bolton Investments reduced its stake in Concordia Healthcare Corp by 3.93% during the most recent quarter end. The investment management company now holds a total of 1,812,262 shares of Concordia ...Is Concordia Healthcare Corp. a Buy on Takeover Rumours?The Motley Fool CanadaConcordia Healthcare Corp. (NASDAQ:CXRX) Latest Broker CoverageRisers & FallersConcordia Healthcare (CXRX) Rating Increased to Hold at Zacks Investment ResearchWeb Breaking NewsCCH Daily News -Franklin Independentall 7 news articles »
04/26/16 01:02 PMConcordia Healthcare Corp (NASDAQ:CXRX) Share Rating Recap - B.O.D.Y Confidential - Concordia Healthcare Corp (NASDAQ:CXRX) Share Rating RecapB.O.D.Y ConfidentialShares of Concordia Healthcare Corp (NASDAQ:CXRX) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly from ...
04/25/16 02:40 PMETF’s with exposure to Concordia Healthcare Corp. : April 25, 2016 -
04/23/16 12:00 PMBenzinga's Volume Movers - Benzinga - Benzinga's Volume MoversBenzingaConcordia Healthcare Corp CXRX 6.46% shares climbed 4.68 percent to $31.93. The volume of Concordia Healthcare shares traded was 1267 percent higher than normal. Blackstone Group LP BX 1.13% is considering a bid for Concordia Healthcare, ...and more »
About Concordia Healthcare

Concordia Healthcare logoConcordia Healthcare Corp. is a Canada-based diverse healthcare company. The Company is focused on legacy pharmaceutical products and orphan drugs. The Company operates through three segments, which includes Legacy Pharmaceutical Division, Concordia Pharmaceuticals Inc., which consists of 23 products, including Nilandron, for the treatment of metastatic prostate cancer; Dibenzyline, for the treatment of pheochromocytoma; Lanoxin, for the treatment of mild-to-moderate heart failure and atrial fibrillation; Plaquenil, for the treatment of lupus and rheumatoid arthritis; Donnatal, for the treatment of irritable bowel syndrome, and Zonegran (zonisamide), for treatment of partial seizures in adults with epilepsy. Its Specialty Healthcare Distribution (SHD) Division, Complete Medical Homecare, is engaged in the distribution of medical supplies focused on diabetes and related conditions. Its Orphan Drugs Division, Concordia Laboratories Inc., is engaged in the manufacture of PHOTOFRIN.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CXRX
  • CUSIP:
Key Metrics:
  • Previous Close: $21.37
  • 50 Day Moving Average: $26.39
  • 200 Day Moving Average: $29.55
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $1.09B
  • Current Quarter EPS Consensus Estimate: $6.35 EPS
Additional Links:
Concordia Healthcare (NASDAQ:CXRX) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha